SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL’s tSMS® Platform
Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc. Funding for the research and method development provided…
Pharmaceuticals, Biotechnology and Life Sciences
Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc. Funding for the research and method development provided…
OPPC OPPC TEMPE, Ariz., Sept. 23, 2021 (GLOBE NEWSWIRE) — OnePoint Patient Care has published a newly updated and vastly…
BURBANK, CA, Sept. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated bioceutical company with R&D, manufacturing,…
NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Sept. 23, 2021 (GLOBE NEWSWIRE) —…
Peer-Reviewed Paper is Largest Real-World Data Set of TMS Seizure Risk Across Device ManufacturersMALVERN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE)…
Press Release Immunocore announces publication of phase 3 data comparing tebentafusp with investigator’s choice in The New England Journal of…
TORONTO, Sept. 22, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”),…
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) —…
BRIDGEWATER, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a specialty pharmaceutical…
After safety review The Connection study is now again open to recruit the smallest infants. Following the completion of the…